Apellis Pharmaceuticals (APLS) Earnings Date & Reports

Industry: @Medical Distributors

A.I. Advisor

published Earnings

APLS is expected to report earnings to fall 11.27% to -26 cents per share on November 04

Apellis Pharmaceuticals APLS Stock Earnings Reports

Q3'24

Est.

$-0.27

Q2'24

Beat

by $0.01

Q1'24

Missed

by $0.07

Q4'23

Est.

$-0.73

Q3'23

Missed

by $0.18

The last earnings report on August 01 showed earnings per share of -30 cents, beating the estimate of -30 cents. With 1.85M shares outstanding, the current market capitalization sits at 4.78B.

View a ticker or compare two or three

Compare

APLS

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For APLS
(Try 14 days for $1 only)

Ad is loading...

A.I.Advisor

published price charts

View to see Real Time Patterns for APLS (Try 14 days for $1 only)

A.I. Advisor

published General Information

General Information

a developer of therapeutics and drug delivery technologies to address chronic inflammatory diseases

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Medical Distributors

Address

100 Fifth Avenue

Phone

+1 617 977-5700

Employees

706

Web

https://www.apellis.com